Skip to main content

Table 5 Description of survival of groupings in the entire set of patients (see Fig. 2)

From: The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study

 

Mean ST (mo)

Medium ST (mo)

1-year CSR (95%CI)

5-year CSR (95%CI)

0-year CSR (95%CI)

OS of BMI grouping

<25

102.35

135.00

0.897(0.784–0.952)

0.733(0.587–0.835)

0.699(0.541–0.811)

≥25

129.00

0.956(0.0–1.0)

0.927(0.0–1.0)

0.927 (0.0–1.0)

OS of PLN grouping

No

124.81

135.00

0.975(0.903–0.994)

0.920(0.830–0.963)

0.897(0.793–0.951)

Yes

75.65

61.00

0.800(0.000–1.000)

0.540(0.002–0.943)

0.450(0.006–0.884)

CSS of PLN grouping

No

126.37

135.00

0.987(0.913–0.998)

0.932(0.843–0.971)

0.909(0.804–0.959)

Yes

98.10

0.861(0.000–1.000)

0.649(0.000–0.985)

0.649(0.000–0.985)

  1. ST: survival time; CSR: cumulative survival rate; OS: overall survival; CSS: cancer-specific surival; BMI: body mass index; PLN: positive lymph nodes